Table 5. Adjusted risk differences of five-year CIN3+ per 10,000 women by risk model (n=167,171).
Risk Group | No. cases/ non-cases | BLM | LEXPIT | Logistic* | |||
---|---|---|---|---|---|---|---|
Est | 95% CI | Est | 95% CI | Est | 95% CI | ||
HPV−/Pap− (Ref.) | 84/152117 | 9 | (6, 12) | 9 | (6, 12) | 9 | (6, 13) |
HPV+/Pap− | 57/2264 | 298 | (240, 355) | 298 | (240, 355) | 294 | (234, 353) |
HPV−/Pap+ | 13/4841 | 17 | (4, 30) | 18 | (5, 31) | 1 | (-2, 3) |
HPV+/Pap+ | 221/7574 | 315 | (256, 374) | 315 | (257, 374) | 313 | (226, 400) |
standardized by summing over confounders